Regulatory actions for Aug. 10, 2026Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aclaris, Alebund, Bavarian, Bioinvent, Grail, Kardium, Novartis, Nrx, Replimune, Transthera.